FDA-Drug2026-04-15Class IIMISBRANDING
Teva Isotretinoin 40 mg capsules recalled for inconsistent strength
What this means
Teva Pharmaceuticals is recalling certain batches of Isotretinoin 40 mg capsules because some capsules may be too strong (superpotent) or too weak (subpotent). This medication is a prescription acne treatment that requires precise dosing. The affected batches were distributed in Florida, Ohio, Puerto Rico, and Mississippi.
- Contact your pharmacy or prescriber if you have one of the affected lots (100075305, 100075512, or 100076103)
- Do not stop taking Isotretinoin without talking to your doctor
- Ask your pharmacist to verify your prescription is not from a recalled batch
The agency's original wording
Hazard
Superpotent and Subpotent
Intended for
Adults
Illnesses reported
None reported
Sold states
FL, OH, PR & MS
Affected count
8376 packages
Manufactured in
400 Interpace Pkwy Bldg A, Parsippany, NJ, United States
Products
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0446-2026More Teva recalls
- FDA-Drug2026-09-09Teva trazodone 50 mg tablets recalled for foreign tablets in bottles
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.